Reaction
Central Vision Loss reporting signals
As of the last recalculation, Central Vision Loss appears in 213 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 153.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 12 | 153.3 | 153.5 |
| Aflibercept | 16 | 54.1 | 54.1 |
| Oseltamivir | 4 | 50.0 | 50.0 |
| Ranibizumab | 12 | 46.7 | 46.8 |
| Pertuzumab | 11 | 41.6 | 41.7 |